0001077183-21-000087.txt : 20210303
0001077183-21-000087.hdr.sgml : 20210303
20210303201940
ACCESSION NUMBER: 0001077183-21-000087
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210301
FILED AS OF DATE: 20210303
DATE AS OF CHANGE: 20210303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McKenzie Kathryn B
CENTRAL INDEX KEY: 0001720001
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35756
FILM NUMBER: 21711984
MAIL ADDRESS:
STREET 1: 12780 WESTLINKS DRIVE
CITY: FORT MYERS
STATE: FL
ZIP: 33913
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEOGENOMICS INC
CENTRAL INDEX KEY: 0001077183
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734]
IRS NUMBER: 742897368
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12701 COMMONWEALTH DRIVE
STREET 2: SUITE 9
CITY: FORT MYERS
STATE: FL
ZIP: 33913
BUSINESS PHONE: 9419231949
MAIL ADDRESS:
STREET 1: 12701 COMMONWEALTH DRIVE
STREET 2: SUITE 9
CITY: FORT MYERS
STATE: FL
ZIP: 33913
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICAN COMMUNICATIONS ENTERPRISES INC
DATE OF NAME CHANGE: 19990120
4
1
wf-form4_161482075291006.xml
FORM 4
X0306
4
2021-03-01
0
0001077183
NEOGENOMICS INC
NEO
0001720001
McKenzie Kathryn B
12701 COMMONWEALTH DRIVE
SUITE 9
FORT MYERS
FL
33913
0
1
0
0
Chief Financial Officer
Common Stock
2021-03-01
4
F
0
169
0
D
7760
D
Common Stock
2021-03-02
4
F
0
432
0
D
7328
D
Common Stock
2021-03-02
4
A
0
6207
0
A
13535
D
Stock Option (Right to Buy)
9.07
2022-10-18
Common Stock
25000.0
25000
D
Stock Option (Right to Buy)
8.03
2023-02-26
Common Stock
40000.0
40000
D
Stock Option (Right to Buy)
19.6
2024-03-01
Common Stock
13894.0
13894
D
Stock Option (Right to Buy)
28.33
2027-03-02
Common Stock
37514.0
37514
D
Stock Option (Right to Buy)
53.17
2021-03-02
4
A
0
35171
53.17
A
2028-03-02
Common Stock
35171.0
35171
D
Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 1, 2021 vesting of restricted stock.
Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 2, 2021 vesting of restricted stock.
On October 17, 2017, Ms. McKenzie was granted 25,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
On February 26, 2018, Ms. McKenzie was granted 48,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
On March 1, 2019, Ms. McKenzie was granted 13,894 stock options. These options vest ratably over the first four anniversary dates of the grant date.
On March 2, 2020, Ms. McKenzie was granted 37,514 stock options. These options vest ratably over the first four anniversary dates of the grant date.
On March 2, 2021, Ms. McKenzie was granted 35,171 stock options. These options vest ratably over the first four anniversary dates of the grant date.
/s/ Kathryn B McKenzie
2021-03-03